ArticleMolecular therapy oncolytics2020

Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy.

Fanny Tzelepis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.